Bullfrog AI Holdings, Inc. 已正式宣布与一家位列全球前五的顶尖制药公司签署商业合作协议。该协议的核心目标，是运用其先进的人工智能技术平台，针对重度抑郁症这一重大公共卫生挑战，进行创新治疗靶点的识别与优先级排序工作。此次合作标志着人工智能在精神疾病药物研发领域的深度应用迈出了关键一步。
Bullfrog AI Holdings, Inc. 已正式宣布与一家位列全球前五的顶尖制药公司签署商业合作协议。该协议的核心目标，是运用其先进的人工智能技术平台，针对重度抑郁症这一重大公共卫生挑战，进行创新治疗靶点的识别与优先级排序工作。此次合作标志着人工智能在精神疾病药物研发领域的深度应用迈出了关键一步。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.